Last $1.82 USD
Change Today -0.03 / -1.62%
Volume 2.3M
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stuart D. Sedlack M.B.A.

Senior Vice President of Corporate Development, Amarin Corporation plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

49--

Background*

Mr. Stuart D. Sedlack, MBA serves as Senior Vice President of Business Development at Velocity Pharmaceutical Development, LLC. Mr. Sedlack served as Senior Vice President of Corporate Development at Amarin Corporation plc (also known as Amarin Pharmaceuticals). Mr. Sedlack joins VPD with a significant record of achievement sourcing, negotiating and managing partnerships in the life science industry. He was responsible for strategic and operational initiatives including ...

Read Full Background

Corporate Headquarters*

2 Pembroke House
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 669 9020
Fax: --

Board Members Memberships*

2004-N/A
Former Director

Education*

Bachelor's Degree
University of Richmond
BA
University of Richmond
BS
University of Richmond
MBA
Babson College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.82 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
W. Thomas Amick Chief Executive Officer, President and Director
Dendreon Corp.
--
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
--
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORPORATION PLC -ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.